Cathie Wood’s ARK ETF published their daily trades for Thursday, October 17th, 2024, with a notable focus on the biotech sector. The most significant investment of the day was in CRISPR Therapeutics AG (NASDAQ:CRSP), where ARK bought a total of 91,665 shares across its ARKK and ARKG ETFs, amounting to a substantial $4,491,585. This purchase continues a trend for ARK, which has been consistently increasing its stake in the gene-editing company, indicating a strong conviction in CRISPR’s potential.
Another major buy for the day was in Cerus Corp (NASDAQ:), with ARK acquiring 466,684 shares for a total value of $840,031. This move suggests a growing interest in the biomedical products company, as it was the second-largest dollar-value trade of the day.
ARK also increased its holdings in Intellia Therapeutics Inc (NASDAQ:) by purchasing 29,739 shares valued at $612,028, further…
